health_en

Latest global data finds nearly 8 million deaths from smoking in 2019, and 90% of new smokers addicted by age 25

The global number of smokers continues to rise, with smoking causing nearly 8 million deaths in 2019, including one in five male deaths. 90% of new smokers become addicted by age 25 – preventing adolescents from starting is crucial for changing the course of the epidemic for the next generation. Countries must meet their commitments […]

thaipr.net

1 มิ.ย. 64

CardiacSense’s medical watch was handpicked to remotely monitor vital signs and general medical condition of the Israeli Astronaut’s vitals while in space

CardiacSense, a Medtech company and the Israel Aerospace Medicine Institute were selected to send CardiacSense’s medical watch to space. The clinically verified medical grade watch enables continuous, long-term, medical grade and comfortable patient monitoring without the need to implant invasive cardiac monitors. CardiacSense is pleased to announce that their medical watch will monitor Eytan Stibbe’s vital […]

thaipr.net

31 พ.ค. 64

MTD Group takes part in the global effort to accelerate the COVID-19 vaccination, thanks to its new Low Dead Space syringes

In delivering the COVID-19 global vaccination campaign, it is of paramount importance to be able to maximize the number of individuals that can benefit from the available vaccine vials. In particular, the use of low dead space (LDS) syringes can enable HCPs to extract more doses than those originally foreseen for each vial. As an example, […]

thaipr.net

31 พ.ค. 64

CStone Announces the First-in-Class Registrational Clinical Trial of Sugemalimab Met its Primary Endpoint in Stage III NSCLC and Plans to Submit a New Drug Application

– Sugemalimab becomes the world’s first anti-PD-1/PD-L1 monoclonal antibody to successfully improve progression-free survival (PFS) in patients with stage III non-small-cell lung cancer (NSCLC) without disease progression after concurrent or sequential chemoradiotherapy – Sugemalimab is also the world’s first anti-PD-1/PD-L1 monoclonal antibody covering both locally advanced/unresectable (stage III) and metastatic (stage…

thaipr.net

28 พ.ค. 64

GenapSys Announces $70 Million in Series D Equity Financing and Expansion of its Board of Directors

Capital will enable continued advancement of GenapSys’ electronic-based, next-generation sequencing platform GenapSys, Inc. (GenapSys), a company developing a highly accurate and scalable electronic sequencing platform, today announced it has raised $70 million in a Series D equity financing. Investors in the round included Farallon Capital Management, L.L.C., Soleus Capital, an affiliate of PBM Capital, and additional new […]

thaipr.net

28 พ.ค. 64
1 … 109 110 111 112 113 … 128

Copyright © 2025 Dataxet Limited (บริษัท ดาต้าเซ็ต จำกัด). All Rights Reserved.